USP and Public Policy

usp public policy
Left
usp public policy

Refine Your Search

All Results
USP Global Public Policy Position: Fostering the Use of Novel Excipients in Drug Products
USP Global Public Policy Position: Fostering the Use of Novel Excipients in Drug Products; Published 2024. Learn More
USP Global Policy Position: Excipients: A Blind Spot in Ensuring Medicine Quality and Supply Chain Resilience
USP Global Policy Position: Excipients: A Blind Spot in Ensuring Medicine Quality and Supply Chain Resilience; Published 2024 Learn More
USP Global Public Policy Position: Identifying and addressing vulnerabilities in the upstream medicines supply chain to build resilience and reduce drug shortages
Identifying and addressing vulnerabilities in the upstream pharmaceutical supply chain are essential to mitigating and preventing drug shortages and to ensuring patients have access to the critical… Learn More
USP Global Public Policy Position: Recognizing Challenges and Opportunities to Support Adoption of Advanced Manufacturing Technologies for Medical Products
USP Global Public Policy Position on advanced manufacturing technologies (AMTs) for medical products. Published in 2024. Learn More
USP Global Public Policy Position: Addressing Antimicrobial Resistance
USP supports comprehensive policies and programs to address AMR, including building capabilities among global stakeholders to reduce the proliferation of poor-quality medicines and advocating and… Learn More
USP Global Public Policy Position: Regulatory reform is necessary to help ensure the quality of dietary supplements
USP Global Public Policy Position published 2024 Learn More
USP Global Public Policy Position - Combatting Substandard and Falsified Medicines
USP supports a comprehensive public policy framework to combat substandard and falsified medicines, including advancing stewardship of quality pharmaceutical products and practices, and building the… Learn More

Document Classification

Topics